Details of the Drug

General Information of Drug (ID: DMGKJ8N)

Drug Name

Engineered hnCD16 iNK Cell

Synonyms

FT516

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04363346) Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia. U.S. National Institutes of Health.